A Comparative Clinical Assessment of Intrathecal Dexmedetomidine and Fentanyl as an Adjuvant to Isobaric Levobupivacaine in Patients Posted for Lower Limb Orthopaedic Surgery
Authors/Creators
- 1. Assistant Professor, Department of Anesthesiology, Jawaharlal Nehru Medical College & Hospital, Bhagalpur, Bihar, India
- 2. Senior Resident, Department of Anesthesiology, Jawaharlal Nehru Medical College & Hospital, Bhagalpur, Bihar, India
- 3. Associate Professor, Department of Anesthesiology, Jawaharlal Nehru Medical College & Hospital, Bhagalpur, Bihar, India
Description
Aim: The aim of the present study was to compare the efficacy and safety of 25 mcg of fentanyl vs 5 mcg dexmedetomidine as an adjuvant in 0.5% of 2.5 ml of isobaric levobupivacaine in lower limb orthopaedic surgery. Methods: The present study was conducted in the Department of Anesthesiology, Jawaharlal Nehru Medical College & Hospital, Bhagalpur, Bihar, India. The study participants were randomly divided into three groups. The study population consisted of 90 adult patients who were classified as American Society of Anesthesiologists (ASA) physical status I or II, undergoing elective lower limb orthopaedic surgery under spinal anesthesia. Results: In the present study, male dominated in all the three groups as compared to females. The patients were more in ASA I as compared to ASA II. The mean time for onset of sensory block was 11.04 ±4.21 min in the saline group and 8.76±2.99 min in the dexmedetomidine group and 2.28±1.42 min in the fentanyl group. The mean time taken to achieve maximum sensory block in group A was 16.18±4.83 min, in group D was 14.16±3.42 min and in group F it was 5.52±1.67 min so maximum sensory block was achieved earlier in group. Peak level of sensory block attained in the fentanyl group was T4 and the peak level of sensory block in dexmedetomidine group was T6 and in the saline group peak level was T8. Conclusion: Dexmedetomidine group has longer onset of and duration of sensory block and effective postoperative analgesia and fewer side effect as compared to fentanyl group.
Abstract (English)
Aim: The aim of the present study was to compare the efficacy and safety of 25 mcg of fentanyl vs 5 mcg dexmedetomidine as an adjuvant in 0.5% of 2.5 ml of isobaric levobupivacaine in lower limb orthopaedic surgery. Methods: The present study was conducted in the Department of Anesthesiology, Jawaharlal Nehru Medical College & Hospital, Bhagalpur, Bihar, India. The study participants were randomly divided into three groups. The study population consisted of 90 adult patients who were classified as American Society of Anesthesiologists (ASA) physical status I or II, undergoing elective lower limb orthopaedic surgery under spinal anesthesia. Results: In the present study, male dominated in all the three groups as compared to females. The patients were more in ASA I as compared to ASA II. The mean time for onset of sensory block was 11.04 ±4.21 min in the saline group and 8.76±2.99 min in the dexmedetomidine group and 2.28±1.42 min in the fentanyl group. The mean time taken to achieve maximum sensory block in group A was 16.18±4.83 min, in group D was 14.16±3.42 min and in group F it was 5.52±1.67 min so maximum sensory block was achieved earlier in group. Peak level of sensory block attained in the fentanyl group was T4 and the peak level of sensory block in dexmedetomidine group was T6 and in the saline group peak level was T8. Conclusion: Dexmedetomidine group has longer onset of and duration of sensory block and effective postoperative analgesia and fewer side effect as compared to fentanyl group.
Files
IJPCR,Vol15,Issue2,Article27.pdf
Files
(317.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:3920101a0ac739445e4a931c1a8dd319
|
317.3 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-02-03
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue2,Article27.pdf
- Development Status
- Active
References
- 1. Verma R, Kohli M, Kushwaha J, Gupta R, Bogra J, Raman R. A Comparative study of intrathecal dexmedetomidine and fentanyl as adjuvants to Bupivacaine. J Anaesthesiol Clin Pharmacol 2011;27(3):339. 2. Borgeat A, Aguirre J. Update on local anesthetics. Curr Opin Anaesthesiol 2010;23(4):466–471. 3. Alahuhta S, Kangas-Saarela T, Hollmén AI, Edström HH. Visceral pain during caesarean section under spinal and epidural anaesthesia with bupivacaine. Acta Anaesthesiol Scand 1990; 34:95-8. 4. Shah A, Patel I, Gandhi R. Haemodynamic effects of intrathecal dexmedetomidine added to ropivacaine intraoperatively and for postoperative analgesia. Int J Basic Clin Pharmacol. 2013;2(1):26–9. 5. Panzer O, Moitra V, Sladen RN. Pharmacology of sedative-analgesic agents: Dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists. Crit Care Clin. 2009;25(3):451–69. vii 6. Bekker A, Sturaitis M, Bloom M, Moric M, Golfinos J, Parker E, Babu R, Pitti A. The effect of dexmedetomidine on preoperative hemodynamics in patients undergoing craniotomy. Anesth Analg. 2008;107(4):1340–7. 7. Sudheesh K, Harsoor S. Dexmedetomidine in anaesthesia practice: a wonder drug? Indian J Anaesth. 2011;55(4):323–4. 8. Liu SS, McDonald SB. Current issues in spinal anesthesia. Anesthesiology. 2001;94(5):888–906. 9. Mohamed T, Susheela I, Balakrishnan BP, Kaniyil S. Dexmedetomidine as adjuvant to lower doses of intrathecal bupivacaine for lower limb orthopedic surgeries. Anesth Essays Res. 2017;11(3):681–5. 10. Saadalla AET, Khalifa OYA. Influence of Addition of Dexmedetomidine or Fentanyl to Bupivacaine Lumber Spinal Subarachnoid Anesthesia for Inguinal Hernioplasty. Anesth Essays Res. 2017;11(3):554–7. 11. Farooq N, Singh RB, Sarkar A, Rasheed MA, Choubey S. To evaluate the efficacy of fentanyl and Dexmedetomidine as adjuvant to Ropivacaine in brachial plexus block: a double-blind, prospective. Randomized Study Anesth Essays Res. 2017;11(3):730–9. 12. Kamal MH, Ibrahim JH, Saaed AA, Zayed MS, Magdy M. Comparison of Intrathecal Dexmedetomidine and Fentanyl as Adjuvants to Levobupivacaine in Parturients Undergoing Elective Cesarean Sections. Med J Cairo Univ 2017;85(2):593–600. 13. Shelly MP. Editorial I: Dexmedetomidine: a real innovation or more of the same? British Journal of Anaesthesia. 2001 Nov 1;87(5):677-8. 14. Nayagam HA, Ratan Singh N, Shanti Singh H. A prospective randomised double-blind study of intrathecal fentanyl and dexmedetomidine added to low dose bupivacaine for spinal anesthesia for lower abdominalsurgeries. Indian J Anaesth 2014;58(4):430–435. 15. Al-Ghanem SM, Massad IM, AlMustafa MM, Al-Zaben KR, Qudaisat IY, Qatawneh AM, Abu-Ali HM. Effect of adding dexmedetomidine versus fentanyl to intrathecal bupivacaine on spinal block characteristics in gynecological procedures: A double blind controlled study. American journal of applied sciences. 2009;6(5):882. 16. Basuni AS, Ezz HAA. Dexmedetomidine as supplement to low dose levobupivacaine spinal anesthesia for knee arthroscopy. Egypt J Anaesth 2014;30(2):149–153. 17. Gupta R, Verma R, Bogra J, Kohli M, Raman R, Kushwaha JK. A comparative study of intrathecal dexmedetomidine and fentanyl as adjuvants to bupivacaine. Journal of Anaesthesiology Clinical Pharmacology. 2011 Jul 1;27(3):339- 43. 18. Ahmad R. A Comparative Study of Intrathecal Low Dose Bupivacaine and Dexmedetomidine with Low Dose Bupivacaine and Fentanyl. IOSR J Dent Med Sci 2016;15(4):09–17. 19. Khan AL, Singh RB, Tripathi RK, Choubey S. A comparative study between intrathecal dexmedetomidine and fentanyl as adjuvant to intrathecal bupivacaine in lower abdominal surgeries: A randomized trial. Anesth essays Res 2015;9(2):139–148. 20. Safari F, Aminnejad R, Mohajerani SA, Farivar F, Mottaghi K, Safdari H. Intrathecal Dexmedetomidine and Fentanyl as Adjuvant to Bupivacaine on Duration of Spinal Block in Addicted Patients. Anesthesiol Pain Med 2016;6(1):1–8. 21. Mahendru V, Tewari A, Katyal S, Grewal A, Singh Mr, Katyal R. A comparison of intrathecal dexmedetomidine, clonidine, and fentanyl as adjuvants to hyperbaric bupivacaine for lower limb surgery: A double-blind controlled study. J Anaesthesiol Clin Pharmacol 2013;29(4):496. 22. Acendra A. H. Y., Sampayo F. H., Robles A. C. W., Ariza M. A. V., León J. S. T., & Badillo L. Y. E. Association between Guillain-Barré Syndrome and Application of the Janssen Vaccine. Journal of Medical Research and Health Sciences. 2022; 5(4): 1950– 1954.